Background:

The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.

Applications:

ELISA, IHC

Name of antibody:

RASSF3

Immunogen:

Fusion protein of human RASSF3

Full name:

Ras association (RalGDS/AF-6) domain family member 3

Synonyms：

RASSF5

SwissProt:

Q86WH2

ELISA Recommended dilution:

2000-10000

IHC positive control:

Human breast cancer and Human liver cancer

IHC Recommend dilution:

30-150